D-245-2013 Class III Terminated

Recalled by Teva Pharmaceuticals USA, Inc. — Sellersville, PA

FDA drug recall D-245-2013 was initiated by Teva Pharmaceuticals USA, Inc. on Mar 12, 2013 and is designated Class III. Reason for recall: Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance. The recall status is terminated (terminated Jan 15, 2014). Affected quantity: 17,661 blister cards.

Recall details

Product Type
Drugs
Report Date
Apr 17, 2013
Initiation Date
Mar 12, 2013
Termination Date
Jan 15, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,661 blister cards

Product description

Portia (levonorgestrel and ethinyl estradiol) Tablets, USP, 0.15 mg/0.03 mg, 28-count tablets (containing 21 pink tablets followed by 7 white tablets) per blister card packaged in 6 blister cards per carton, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, NDC 0555-9020-58.

Reason for recall

Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.

Distribution pattern

Nationwide

Code information

Lot #: 33801951A, and 33802189A, Exp 03/13

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-245-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-245-2013. Report a data issue: hello@regdatalab.com.